ArchiMed related stories
All articles and analysis
GHO Capital gathers over €2bn for Europe’s largest ever healthcare fundThe latest vehicle is more than double the size of its predecessor, which raised €975m in 2019.
PEI 300 2021: Six firms making their mark in this year's rankingThe firms from across the PEI 300 that made the headlines this year.
PEI Awards 2020: EMEA winnersFind out who took the plaudits in Fund, Deal and Exit of the Year, plus the different markets and geographies across the region.
Side Letter: Spin-out tips & tricks, CVC's vaccine bets, Indonesia's SWF hiresThree spin-out experts share their top tips for going it alone our latest video. Plus: Indonesia's new SWF will have a strong PE pedigree and CDC Group discusses its appetite for emerging markets VC. Here's today's brief, for our valued subscribers only.
France's ArchiMed: Everybody wants to get into healthcareWe catch up with chairman Denis Ribon, whose firm raised €1bn for its largest healthcare fund last year, to discuss the firm’s US expansion and competition in the mid-market.
Millennials move towards social goodA new generation of private equity leaders look poised to revolutionise the industry’s approach to responsible investment.
PEI Awards 2020: Let’s celebrate success in extraordinary timesCast your vote and help decide the outcome in 71 categories making up the 2020 Private Equity International Awards.
Side Letter: Giant Australian PE portfolio sale, Dyal fundraising, how to write a pitch deckMore detail on Aussie Future Fund's multi-billion PE portfolio sale. Plus: Dyal's fundraising prowess; Archimed's US expansion; ILPA gets out to vote; and how to write a pitch deck. Here's today's brief, for our valued subscribers only.
ArchiMed sets sights on US with its largest healthcare fundThe firm held a final close on €1bn for its third fund – Europe’s largest healthcare vehicle – in late August.
Sideletter: LACERS on liquidity; emotions in PE; 44x for ArchiMedHow does it feel to work in PE? Joyous and stressful. Plus: a supercharged healthcare exit in the mid-market and LACERS on the steep rise in capital calls. Here’s today's brief, for our valued subscribers only.